- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle
Patent holdings for IPC class C12N 15/88
Total number of patents in this class: 1959
10-year publication summary
61
|
73
|
100
|
132
|
150
|
146
|
160
|
256
|
306
|
207
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Modernatx, Inc. | 1259 |
81 |
Translate bio, Inc. | 415 |
56 |
The Regents of the University of California | 19887 |
40 |
Massachusetts Institute of Technology | 10041 |
35 |
The Johns Hopkins University | 5662 |
34 |
BioNTech SE | 657 |
30 |
The University of British Columbia | 1497 |
27 |
Flagship Pioneering Innovations V, Inc. | 222 |
23 |
Board of Regents, The University of Texas System | 5782 |
21 |
Arbutus Biopharma Corporation | 177 |
21 |
Intellia Therapeutics, Inc. | 203 |
20 |
Life Technologies Corporation | 3290 |
19 |
NanoVation Therapeutics Inc. | 61 |
18 |
The Trustees of the University of Pennsylvania | 4317 |
17 |
Generation Bio Co. | 148 |
17 |
Alnylam Pharmaceuticals, Inc. | 1152 |
15 |
Molecular Transfer, Inc. | 32 |
14 |
National University Corporation Hokkaido University | 1340 |
14 |
Ramot at Tel-Aviv University Ltd. | 1473 |
14 |
Northwestern University | 3385 |
13 |
Other owners | 1430 |